These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32822862)

  • 1. Special Issue: Mining human microbiome bringing newer paradigms to anticancer therapeutics.
    Sharma AK
    Semin Cancer Biol; 2021 May; 70():1-2. PubMed ID: 32822862
    [No Abstract]   [Full Text] [Related]  

  • 2. Microbiota and cancer immunotherapy: in search of microbial signals.
    Gharaibeh RZ; Jobin C
    Gut; 2019 Mar; 68(3):385-388. PubMed ID: 30530851
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental?
    Hekmatshoar Y; Rahbar Saadat Y; Hosseiniyan Khatibi SM; Ozkan T; Zununi Vahed F; Nariman-Saleh-Fam Z; Pourghassem Gargari B; Sunguroglu A; Zununi Vahed S
    Life Sci; 2019 Sep; 233():116680. PubMed ID: 31344431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy.
    Gori S; Inno A; Belluomini L; Bocus P; Bisoffi Z; Russo A; Arcaro G
    Crit Rev Oncol Hematol; 2019 Nov; 143():139-147. PubMed ID: 31634731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bugs, drugs, and cancer: can the microbiome be a potential therapeutic target for cancer management?
    Chen B; Du G; Guo J; Zhang Y
    Drug Discov Today; 2019 Apr; 24(4):1000-1009. PubMed ID: 30818030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of intestinal microbiota in the response to anti-tumor therapies].
    Vétizou M; Daillère R; Zitvogel L
    Med Sci (Paris); 2016 Nov; 32(11):974-982. PubMed ID: 28008838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenic cell death: A link between gut microbiota and anticancer effects.
    Chen W; Wang S; Wu Y; Shen X; Guo Z; Li Q; Xing D
    Microb Pathog; 2020 Apr; 141():103983. PubMed ID: 31954823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-Associated Microbiome: Where Do We Stand?
    Oliva M; Mulet-Margalef N; Ochoa-De-Olza M; Napoli S; Mas J; Laquente B; Alemany L; Duell EJ; Nuciforo P; Moreno V
    Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulating host gene expression via gut microbiome-microRNA interplay to treat human diseases.
    Mody D; Verma V; Rani V
    Crit Rev Microbiol; 2021 Sep; 47(5):596-611. PubMed ID: 34407384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy.
    Sevcikova A; Izoldova N; Stevurkova V; Kasperova B; Chovanec M; Ciernikova S; Mego M
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metagenomic cross-talk: the regulatory interplay between immunogenomics and the microbiome.
    Levy M; Thaiss CA; Elinav E
    Genome Med; 2015 Nov; 7():120. PubMed ID: 26589591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The microbiome and cancer for clinicians.
    Picardo SL; Coburn B; Hansen AR
    Crit Rev Oncol Hematol; 2019 Sep; 141():1-12. PubMed ID: 31202124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fighting cancer with microbes.
    Dolgin E
    Nature; 2020 Jan; 577(7792):S16-S18. PubMed ID: 31996833
    [No Abstract]   [Full Text] [Related]  

  • 14. Microbiota: a key orchestrator of cancer therapy.
    Roy S; Trinchieri G
    Nat Rev Cancer; 2017 May; 17(5):271-285. PubMed ID: 28303904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies.
    Zitvogel L; Ma Y; Raoult D; Kroemer G; Gajewski TF
    Science; 2018 Mar; 359(6382):1366-1370. PubMed ID: 29567708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of gut microbiota to overcome resistance to immune checkpoint blockade in cancer immunotherapy.
    Huang J; Jiang Z; Wang Y; Fan X; Cai J; Yao X; Liu L; Huang J; He J; Xie C; Wu Q; Cao Y; Leung EL
    Curr Opin Pharmacol; 2020 Oct; 54():1-10. PubMed ID: 32619934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of modulating the gastrointestinal microbiota in cancer patients.
    Morkūnas E; Skiecevičienė J; Kupčinskas J
    Best Pract Res Clin Gastroenterol; 2020; 48-49():101700. PubMed ID: 33317795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics in microbiome ecological balance providing a therapeutic window against cancer.
    Sehrawat N; Yadav M; Singh M; Kumar V; Sharma VR; Sharma AK
    Semin Cancer Biol; 2021 May; 70():24-36. PubMed ID: 32574811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaching precision medicine by tailoring the microbiota.
    Ryu G; Kim H; Koh A
    Mamm Genome; 2021 Aug; 32(4):206-222. PubMed ID: 33646347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer effects of the microbiome and its products.
    Zitvogel L; Daillère R; Roberti MP; Routy B; Kroemer G
    Nat Rev Microbiol; 2017 Aug; 15(8):465-478. PubMed ID: 28529325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.